Japanese Biotech Stock News

TSE:7701
TSE:7701Electronic

Assessing Shimadzu (TSE:7701) Valuation After Improved Nine Month Sales And Net Income Results

What Shimadzu’s Latest Earnings Tell You Shimadzu (TSE:7701) has drawn fresh attention after reporting nine month results to December 31, 2025, with sales of ¥398,722 million and net income of ¥39,087 million compared with the same period a year earlier. See our latest analysis for Shimadzu. The latest earnings update appears to have kept interest in Shimadzu steady, with a 7 day share price return of 1.70% and a 1 year total shareholder return of 5.43%. This suggests modest momentum rather...
TSE:8697
TSE:8697Capital Markets

What Japan Exchange Group (TSE:8697)'s Higher Nine-Month Profits Mean For Shareholders

Japan Exchange Group, Inc. reported past earnings for the nine months ended December 31, 2025, with sales of ¥139,626 million, revenue of ¥139,883 million, net income of ¥54,993 million, and basic earnings per share of ¥53.33, all higher than a year earlier. The simultaneous rise in sales, revenue, and earnings suggests the exchange operator converted higher business activity into stronger profitability over the period. Next, we examine how Japan Exchange Group’s improved net income profile...
TSE:7613
TSE:7613Electronic

Top 3 Asian Dividend Stocks To Enhance Your Portfolio

As Asian markets navigate a landscape marked by volatility in global technology stocks and geopolitical tensions, investors are increasingly looking towards value-oriented segments that have shown resilience. In this environment, dividend stocks can offer stability and income potential, making them an attractive option for those seeking to enhance their portfolios amidst the current market dynamics.
TSE:2768
TSE:2768Trade Distributors

Assessing Sojitz (TSE:2768) Valuation After Strong Nine Month Earnings And Profitability Momentum

Sojitz (TSE:2768) just released nine-month earnings to December 31, 2025, reporting revenue of ¥1,985,795 million and net income of ¥80,421 million, both higher than in the same period a year earlier. See our latest analysis for Sojitz. The earnings update comes after a strong run in the shares, with a 42.27% 90 day share price return and a 90.00% 1 year total shareholder return. This suggests momentum has been building around Sojitz’s recent execution and outlook. If this kind of move has...
TSE:7735
TSE:7735Semiconductor

A Look At SCREEN Holdings (TSE:7735) Valuation After Results, Stock Split And Reaffirmed Guidance

SCREEN Holdings (TSE:7735) has given investors plenty to digest, with nine month results showing lower sales and net income, a planned stock split, and reaffirmed full year earnings guidance, all landing on January 30. See our latest analysis for SCREEN Holdings. The reaffirmed full year guidance and planned stock split sit alongside a strong run in the shares, with a 30 day share price return of 34.64% and a 1 year total shareholder return of 116.24%. This suggests momentum has been building...
TSE:4568
TSE:4568Pharmaceuticals

A Look At Daiichi Sankyo (TSE:4568) Valuation After DATROWAY Priority Review Milestone

Daiichi Sankyo Company (TSE:4568) shares are in focus after the U.S. FDA accepted and granted Priority Review to a supplemental Biologics License Application for DATROWAY in advanced triple negative breast cancer. See our latest analysis for Daiichi Sankyo Company. At a share price of ¥2,952.0, Daiichi Sankyo’s 1 day share price return of 2.89% and 7 day gain of 1.22% contrast with a 30 day share price decline of 16.66% and a 1 year total shareholder return of 19.19% in the red. This suggests...
TSE:7733
TSE:7733Medical Equipment

Olympus (TSE:7733) Valuation Check As New HR And Manufacturing Leaders Join The MedTech Push

Olympus (TSE:7733) has reshaped its senior leadership by appointing Simone Berger as Chief Human Resources Officer and David Shan as Chief Manufacturing and Supply Officer, effective April 1, 2026, following a board meeting that reviewed executive roles. See our latest analysis for Olympus. The executive reshuffle comes after a softer patch for the stock, with a 30 day share price return decline of 7.05% and a 1 year total shareholder return decline of 11.96%, while the recent 7 day share...
TSE:8031
TSE:8031Trade Distributors

Mitsui (TSE:8031) Valuation Check After Buffett Spotlight And Updated Earnings Guidance

Why Mitsui’s latest earnings and Buffett link are back in focus Mitsui (TSE:8031) is back on investor watchlists after renewed attention on Warren Buffett’s Japanese trading house holdings, combined with the company’s latest nine month earnings and fresh full year profit guidance. See our latest analysis for Mitsui. The share price has moved to ¥5,364 after a 3.63% 1 day share price return and 35.22% 90 day share price return. The 1 year total shareholder return of 96.65% suggests strong...
TSE:2413
TSE:2413Healthcare Services

Do M3’s (TSE:2413) Higher EPS Figures Hint At A Deeper Profitability Shift?

M3, Inc. has reported past earnings results for the nine months ended December 31, 2025, with sales of ¥264,395 million and net income of ¥45,237 million, both higher than a year earlier. Earnings per share from continuing operations also increased on both a basic and diluted basis, pointing to improved profitability across the existing business. Next, we will examine how this stronger profitability profile shapes M3’s investment narrative, particularly the implications of higher earnings...